pI: 4.4966 |
Length (AA): 224 |
MW (Da): 25562 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 148 | 2gd5 (A) | 12 | 164 | 15.00 | 0 | 0.09 | 0.74 | -0.12 |
9 | 188 | 4uos (A) | 2 | 177 | 11.00 | 0.6 | 0.04 | 0.960471 | -0.93 |
10 | 220 | 4cgk (A) | 45 | 251 | 13.00 | 0.32 | 0.01 | 1.00286 | 0.2 |
33 | 145 | 2qih (A) | 534 | 645 | 9.00 | 0 | 0 | 0.555064 | -0.09 |
149 | 189 | 4txr (C) | 151 | 190 | 43.00 | 0.053 | 0.11 | 0.538536 | 0.57 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128328)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G10640 | vacuolar protein sorting protein 60.1 |
Arabidopsis thaliana | AT5G04850 | vacuolar protein sorting protein 60.2 |
Brugia malayi | Bm1_52890 | MGC80100 protein |
Candida albicans | CaO19.3401 | similar to S. cerevisiae VPS60 (YDR486C) involved in vacuolar protein sorting |
Candida albicans | CaO19.10904 | similar to S. cerevisiae VPS60 (YDR486C) involved in vacuolar protein sorting |
Caenorhabditis elegans | CELE_F41E6.9 | Protein F41E6.9 |
Dictyostelium discoideum | DDB_G0287993 | SNF7 family protein |
Drosophila melanogaster | Dmel_CG6259 | CG6259 gene product from transcript CG6259-RB |
Echinococcus granulosus | EgrG_001063800 | charged multivesicular body protein 5 |
Entamoeba histolytica | EHI_114790 | SNF7 family protein |
Echinococcus multilocularis | EmuJ_001063800 | charged multivesicular body protein 5 |
Homo sapiens | ENSG00000086065 | charged multivesicular body protein 5 |
Leishmania braziliensis | LbrM.34.0580 | SNF-7-like protein, conserved |
Leishmania donovani | LdBPK_350580.1 | SNF-7-like protein, conserved |
Leishmania infantum | LinJ.35.0580 | SNF-7-like protein, conserved |
Leishmania major | LmjF.35.0580 | SNF-7-like protein, conserved |
Leishmania mexicana | LmxM.34.0580 | SNF-7-like protein, conserved |
Loa Loa (eye worm) | LOAG_11989 | hypothetical protein |
Mus musculus | ENSMUSG00000028419 | charged multivesicular body protein 5 |
Oryza sativa | 4337536 | Os05g0102900 |
Oryza sativa | 9266052 | Os01g0102950 |
Plasmodium berghei | PBANKA_1305700 | vacuolar-sorting protein SNF7, putative |
Plasmodium falciparum | PF3D7_1441800 | vacuolar-sorting protein SNF7, putative |
Plasmodium knowlesi | PKNH_1240500 | vacuolar-sorting protein SNF7, putative |
Plasmodium vivax | PVX_118400 | vacuolar-sorting protein SNF7, putative |
Plasmodium yoelii | PY01293 | CTA1p, putative |
Saccharomyces cerevisiae | YDR486C | Vps60p |
Schistosoma japonicum | Sjp_0076120 | Charged multivesicular body protein 5, putative |
Schistosoma mansoni | Smp_010090 | snf7-related |
Schmidtea mediterranea | mk4.012846.01 | Charged multivesicular body protein 5 |
Schmidtea mediterranea | mk4.002224.04 | Charged multivesicular body protein 5 |
Trypanosoma brucei gambiense | Tbg972.10.4790 | SNF-7-like protein, putative |
Trypanosoma brucei | Tb927.10.3860 | SNF-7-like protein, putative |
Trypanosoma congolense | TcIL3000_10_3200 | SNF-7-like protein, putative |
Trypanosoma cruzi | TcCLB.511001.100 | SNF-7-like protein, putative |
Trypanosoma cruzi | TcCLB.506957.110 | SNF-7-like protein, putative |
Trichomonas vaginalis | TVAG_123830 | Charged multivesicular body protein, putative |
Trichomonas vaginalis | TVAG_396070 | Charged multivesicular body protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.3860 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.3860 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.3860 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.10.3860 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.